Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Eisai Plans Entry Into Nucleic Acid Drug Market

Filed Under: Industry, Pharma Tagged With: , , , , ,

Eisai Co. Ltd. (TYO:4523) is gearing up to make a full-fledged entry into the nucleic acid drug market. Leveraging tie-ups…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of Oligonucleotides…
Daicel Targets 2024 for Launch of Centralized Medical Business
Daicel Targets 2024 for Launch of Centralized Medical…